z-logo
open-access-imgOpen Access
The Impact of Asthma and Chronic Obstructive Pulmonary Disease (COPD) on Patient‐Reported Outcomes in Systemic Lupus Erythematosus (SLE)
Author(s) -
Katz Patricia,
Pedro Sofia,
Trupin Laura,
Yelin Edward,
Michaud Kaleb
Publication year - 2021
Publication title -
acr open rheumatology
Language(s) - English
Resource type - Journals
ISSN - 2578-5745
DOI - 10.1002/acr2.11212
Subject(s) - medicine , copd , asthma , population , incidence (geometry) , physical therapy , systemic lupus erythematosus , disease , environmental health , optics , physics
Background Risk of asthma and chronic obstructive pulmonary disease (COPD) may be elevated in systemic lupus erythematosus (SLE), but little research has studied the impact of these conditions on SLE outcomes. We examined prevalence, incidence, and impact of self‐reported asthma and COPD in two US‐based SLE cohorts (FORWARD and Lupus Outcomes Study [LOS]). Methods Prevalence of asthma and COPD were defined as presence of conditions at individuals’ first interviews; incidence was defined as new reports over the next 3 years. Cross‐sectional associations of asthma/COPD with patient‐reported outcomes (PROs) and longitudinal analyses associations with asthma/COPD at entry with PROs 3 years later were examined. Results In FORWARD, 19.8% and 8.3% participants reported asthma and COPD, respectively, at entry. In LOS, 36.0% reported the presence of either (US population comparisons: asthma, 9.7%; COPD, 6.1%). Cross‐sectionally, asthma/COPD was associated with worse PROs, including disease activity. In FORWARD, individuals with asthma experienced greater worsening of fatigue, pain, and global health ratings longitudinally; individuals with COPD experienced greater increases in self‐reported SLE activity. However, no such patterns were noted in the LOS. Conclusion Asthma and COPD appeared to be more common in SLE than in the general US population and were associated with worse status on PROs cross‐sectionally. Asthma was linked to decrements in PROs longitudinally.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here